ABC.L Regulatory News (ABC)

12 December 2014

ABCAM PLC

("Abcam" or "the Company")

Board Appointment

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Sue Harris as a non-Executive Director on the Abcam Board. Sue will join the Board with immediate effect and will Chair the Audit Committee.

A Chemist by training, Sue has over 30 years of financial and commercial experience. She began her career at Ford Motor Co. before moving to oil company Amerada Hess. Sue subsequently held senior executive roles at Marks & Spencer, across finance and latterly as Head of Corporate Development, and Standard Life where she led the process to float the company on the London Stock Exchange in 2006. She then joined Lloyds Banking Group (LBG) where she was Finance Director of respectively; Cheltenham and Gloucester; LBG's Retail Bank; and LBG Group Finance; and latterly Group Audit Director.

Sue is a Member of the Audit and Assurance Council of the Financial Reporting Council and previously was a Non-Executive Director on the Board of St. James's Place (representing LBG) and a Member of the Audit and Remuneration Committee of the British Bankers' Association. She is Chair of Trustees for KCP Youth and during a ten year association with Mencap chaired both the Finance and Audit Committees. Sue has completed INSEAD's Advanced Management Programme, is a Chartered Management Accountant and has a degree in Chemistry from Manchester University.

Murray Hennessy, Abcam Chairman commented: "I am delighted to welcome Sue to the Abcam Board. She brings a wealth of finance and commercial skills, which combined with her broad corporate experience and scientific background, make her an ideal person to further strengthen the Abcam Board at this exciting time in our journey."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Susan Elizabeth Harris, aged 53 years, has been a director of the following companies during the five years preceding the date of this announcement:

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

For further information please contact:

About Abcam plc

Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices enabling local services, multi-language support sells to over 100 countries. The Company was founded in 1998, and now employs over 740 people. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.